메뉴 건너뛰기




Volumn 51, Issue 8, 2013, Pages 11-18

Efficacy of quetiapine off-label uses: Data synthesis

Author keywords

[No Author keywords available]

Indexed keywords

DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; QUETIAPINE;

EID: 84882594849     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20130709-01     Document Type: Article
Times cited : (16)

References (66)
  • 1
    • 84856882574 scopus 로고    scopus 로고
    • Effect of quetiapine and norquetiapine on anxiety and depression in major psychosis using a pharmacokinetic approach a prospective observational study
    • doi:10.2165/11597330-000000000-00000
    • Altamura, A.C., Moliterno, D., Paletta, S., Buoli, M., Dell'Osso, B., Mauri, M.C., & Bareggi, S.R. (2012). Effect of quetiapine and norquetiapine on anxiety and depression in major psychosis using a pharmacokinetic approach a prospective observational study. Clinical Drug Investigation, 32, 213-219.doi:10.2165/11597330-000000000-00000
    • (2012) Clinical Drug Investigation , vol.32 , pp. 213-219
    • Altamura, A.C.1    Moliterno, D.2    Paletta, S.3    Buoli, M.4    Dell'Osso, B.5    Mauri, M.C.6    Bareggi, S.R.7
  • 2
    • 84870469320 scopus 로고    scopus 로고
    • American Psychiatric Association, (4th ed., text rev.). Washington, DC:Author
    • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC:Author.
    • (2000) Diagnostic and Statistical Manual of Mental Disorders
  • 3
    • 33745737632 scopus 로고    scopus 로고
    • Neuroleptic drugs in dementia: Benefits and harm
    • Ballard, C., & Howard, R. (2006). Neuroleptic drugs in dementia: Benefits and harm. Nature Reviews Neuroscience, 7, 492-500.
    • (2006) Nature Reviews Neuroscience , vol.7 , pp. 492-500
    • Ballard, C.1    Howard, R.2
  • 4
    • 20244384575 scopus 로고    scopus 로고
    • Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial
    • Ballard, C., Margallo-Lana, M., Juszczak, E., Douglas, S., Swann, A., Thomas, A., Jacoby, R. (2005). Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: Randomised double blind placebo controlled trial. BMJ, 330, 874-877.
    • (2005) BMJ , vol.330 , pp. 874-877
    • Ballard, C.1    Margallo-Lana, M.2    Juszczak, E.3    Douglas, S.4    Swann, A.5    Thomas, A.6    Jacoby, R.7
  • 5
    • 77953500268 scopus 로고    scopus 로고
    • Extended release quetiapine fumarate (quetiapine XR): A once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placeboand active-controlled study
    • doi:10.1017/S1461145709990423
    • Bandelow, B., Chouinard, G., Bobes, J., Ahokas, A., Eggens, I., Liu, S., & Eriksson, H. (2010). Extended release quetiapine fumarate (quetiapine XR): A once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placeboand active-controlled study. International Journal of Neuropsychopharmacology, 13, 305-320. doi:10.1017/S1461145709990423
    • (2010) International Journal of Neuropsychopharmacology , vol.13 , pp. 305-320
    • Bandelow, B.1    Chouinard, G.2    Bobes, J.3    Ahokas, A.4    Eggens, I.5    Liu, S.6    Eriksson, H.7
  • 7
    • 77951227428 scopus 로고    scopus 로고
    • A pilot study of quetiapine in patients with bipolar disorder and cocaine dependence
    • Brown, E.S., Gabrielson, B., & Gu, P. (2010). A pilot study of quetiapine in patients with bipolar disorder and cocaine dependence. Journal of Dual Diagnosis, 6, 16-24.
    • (2010) Journal of Dual Diagnosis , vol.6 , pp. 16-24
    • Brown, E.S.1    Gabrielson, B.2    Gu, P.3
  • 8
    • 68649100415 scopus 로고    scopus 로고
    • Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients
    • doi:10.1007/s10597-009-9200-0
    • Cates, M.E., Jackson, C.W., Feldman, J.M., Stimmel, A.E., & Woolley, T.W. (2009). Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients. Community Mental Health Journal, 45, 251-254. doi:10.1007/s10597-009-9200-0
    • (2009) Community Mental Health Journal , vol.45 , pp. 251-254
    • Cates, M.E.1    Jackson, C.W.2    Feldman, J.M.3    Stimmel, A.E.4    Woolley, T.W.5
  • 9
    • 84860991804 scopus 로고    scopus 로고
    • Safety of low doses of quetiapine when used for insomnia
    • doi:10.1345/aph.1Q697
    • Coe, H.V., & Hong, I.S. (2012). Safety of low doses of quetiapine when used for insomnia. Annals of Pharmacotherapy, 46, 718-722. doi:10.1345/aph.1Q697
    • (2012) Annals of Pharmacotherapy , vol.46 , pp. 718-722
    • Coe, H.V.1    Hong, I.S.2
  • 12
    • 80054810300 scopus 로고    scopus 로고
    • National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders
    • doi:10.1176/appi.ajp.2011.11010087
    • Comer, J.S., Mojtabai, R.O., & Olfson, M. (2011). National trends in the antipsychotic treatment of psychiatric outpatients with anxiety disorders. American Journal of Psychiatry, 168, 1057-1065. doi:10.1176/appi.ajp.2011.11010087
    • (2011) American Journal of Psychiatry , vol.168 , pp. 1057-1065
    • Comer, J.S.1    Mojtabai, R.O.2    Olfson, M.3
  • 13
    • 34248232941 scopus 로고    scopus 로고
    • Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions
    • Compton, W.M., Thomas, Y.F., Stinson, F.S., & Grant, B.F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64, 566-576.
    • (2007) Archives of General Psychiatry , vol.64 , pp. 566-576
    • Compton, W.M.1    Thomas, Y.F.2    Stinson, F.S.3    Grant, B.F.4
  • 14
    • 42549085631 scopus 로고    scopus 로고
    • Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder
    • doi:10.1089/cap.2006.0007
    • Conner, D.F., McLaughlin, T.J., & Jeffers-Terry, M. (2008). Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder. Journal of Child and Adolescent Psychopharmacology, 18, 140-156. doi:10.1089/cap.2006.0007
    • (2008) Journal of Child and Adolescent Psychopharmacology , vol.18 , pp. 140-156
    • Conner, D.F.1    McLaughlin, T.J.2    Jeffers-Terry, M.3
  • 15
    • 84856325555 scopus 로고    scopus 로고
    • Tolerability of extended-release quetiapine fumarate compared with immediaterelease quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: A randomised, double-blind, parallel-group study
    • doi:10.1002/gps.2720
    • De Deyn, P.P., Eriksson, H., & Svensson, H. (2012). Tolerability of extended-release quetiapine fumarate compared with immediaterelease quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: A randomised, double-blind, parallel-group study. International Journal of Geriatric Psychiatry, 27, 296-304. doi:10.1002/gps.2720
    • (2012) International Journal of Geriatric Psychiatry , vol.27 , pp. 296-304
    • de Deyn, P.P.1    Eriksson, H.2    Svensson, H.3
  • 16
    • 74949114615 scopus 로고    scopus 로고
    • Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, doubleblind, placebo-controlled pilot study
    • Devlin, J.W., Roberts, R.J., Fong, J.J., Skrobik, Y., Riker, R.R., Hill, N.S., Garpestad, E. (2010). Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, doubleblind, placebo-controlled pilot study. Critical Care Medicine, 38, 419-427.
    • (2010) Critical Care Medicine , vol.38 , pp. 419-427
    • Devlin, J.W.1    Roberts, R.J.2    Fong, J.J.3    Skrobik, Y.4    Riker, R.R.5    Hill, N.S.6    Garpestad, E.7
  • 17
    • 79551572553 scopus 로고    scopus 로고
    • Quetiapine for sleep in patients with dementia
    • doi:10.4140/TCP.n.2010.676
    • Dolder, C.R., & McKinsey, J. (2010). Quetiapine for sleep in patients with dementia. The Consultant Pharmacist, 25, 676-679. doi:10.4140/TCP.n.2010.676
    • (2010) The Consultant Pharmacist , vol.25 , pp. 676-679
    • Dolder, C.R.1    McKinsey, J.2
  • 19
    • 77954437393 scopus 로고    scopus 로고
    • Quetiapine in substance use disorders, abuse and dependence possibility: A review
    • Erdogan, S. (2010). Quetiapine in substance use disorders, abuse and dependence possibility: A review. Turkish Journal of Psychiatry, 21, 167-175.
    • (2010) Turkish Journal of Psychiatry , vol.21 , pp. 167-175
    • Erdogan, S.1
  • 20
    • 79955616401 scopus 로고    scopus 로고
    • The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study
    • Gabriel, A. (2011). The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study. La Clinica Terapeutica, 162, 113-118.
    • (2011) La Clinica Terapeutica , vol.162 , pp. 113-118
    • Gabriel, A.1
  • 22
    • 0002635865 scopus 로고    scopus 로고
    • Anxiety disorders
    • In R.E. Hales, S.C. Yudofsky, & G.O. Gabbard (Eds.), 5th ed.). Arlington, VA: American Psychiatric Publishing
    • Hollander, E., & Simeon, D. (2010). Anxiety disorders. In R.E. Hales, S.C. Yudofsky, & G.O. Gabbard (Eds.), The American Psychiatric Publishing textbook of clinical psychiatry (5th ed.). Arlington, VA: American Psychiatric Publishing.
    • (2010) The American Psychiatric Publishing Textbook of Clinical Psychiatry
    • Hollander, E.1    Simeon, D.2
  • 23
    • 23644433193 scopus 로고    scopus 로고
    • Quetiapine for insomnia in Parkinson disease: Results from an openlabel trial
    • Juri, C., Chaná, P., Tapia, J., Kunstmann, C., & Parrao, T. (2005). Quetiapine for insomnia in Parkinson disease: Results from an openlabel trial. Clinical Neuropharmacology, 28, 185-187.
    • (2005) Clinical Neuropharmacology , vol.28 , pp. 185-187
    • Juri, C.1    Chaná, P.2    Tapia, J.3    Kunstmann, C.4    Parrao, T.5
  • 25
    • 78650809435 scopus 로고    scopus 로고
    • Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: A long-term, randomized, placebocontrolled trial
    • doi:10.1097/ YIC.0b013e32833e34d9
    • Katzman, M.A., Brawman-Mintzer, O., Reyes, E.B., Olausson, B., Liu, S., & Eriksson, H. (2011). Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: A long-term, randomized, placebocontrolled trial. International Clinical Psychopharmacology, 26, 11-24. doi:10.1097/ YIC.0b013e32833e34d9
    • (2011) International Clinical Psychopharmacology , vol.26 , pp. 11-24
    • Katzman, M.A.1    Brawman-Mintzer, O.2    Reyes, E.B.3    Olausson, B.4    Liu, S.5    Eriksson, H.6
  • 26
    • 53149142767 scopus 로고    scopus 로고
    • Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, openlabel pilot trial
    • doi:10.1016/j.janxdis.2008.03.002
    • Katzman, M.A., Vermani, M., Jacobs, L., Marcus, M., Kong, B., Lessard, S., Gendron, A. (2008). Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, openlabel pilot trial. Journal of Anxiety Disorders, 22, 1480-1486. doi:10.1016/j.janxdis.2008.03.002
    • (2008) Journal of Anxiety Disorders , vol.22 , pp. 1480-1486
    • Katzman, M.A.1    Vermani, M.2    Jacobs, L.3    Marcus, M.4    Kong, B.5    Lessard, S.6    Gendron, A.7
  • 28
    • 79960573121 scopus 로고    scopus 로고
    • A randomized, double-blind study of oncedaily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder
    • doi:10.1097/JCP.0b013e318224864d
    • Khan, A., Joyce, M., Atkinson, S., Eggens, I., Baldytcheva, I., & Eriksson, H. (2011). A randomized, double-blind study of oncedaily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalized anxiety disorder. Journal of Clinical Psychopharmacology, 31, 418-428. doi:10.1097/JCP.0b013e318224864d
    • (2011) Journal of Clinical Psychopharmacology , vol.31 , pp. 418-428
    • Khan, A.1    Joyce, M.2    Atkinson, S.3    Eggens, I.4    Baldytcheva, I.5    Eriksson, H.6
  • 30
    • 84857503966 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcoholdependent patients
    • doi:10.1111/j.1530-0277.2011.01649.x
    • Litten, R.Z., Fertig, J.B., Falk, D.E., Ryan, M.L., Mattson, M.E., Collins, J.F., Stout, R. (2012). A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcoholdependent patients. Alcoholism Clinical and Experimental Research, 36, 406-416. doi:10.1111/j.1530-0277.2011.01649.x
    • (2012) Alcoholism Clinical and Experimental Research , vol.36 , pp. 406-416
    • Litten, R.Z.1    Fertig, J.B.2    Falk, D.E.3    Ryan, M.L.4    Mattson, M.E.5    Collins, J.F.6    Stout, R.7
  • 31
    • 77956155318 scopus 로고    scopus 로고
    • Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder
    • doi:10.1592/phco.30.9.942
    • Lorenz, R.A., Jackson, C.W., & Saitz, M. (2010). Adjunctive use of atypical antipsychotics for treatment-resistant generalized anxiety disorder. Pharmacotherapy, 30, 942-951. doi:10.1592/phco.30.9.942
    • (2010) Pharmacotherapy , vol.30 , pp. 942-951
    • Lorenz, R.A.1    Jackson, C.W.2    Saitz, M.3
  • 32
    • 84863527915 scopus 로고    scopus 로고
    • Postoperative delirium: A 76-year-old woman with delirium following surgery
    • Marcantonio, E.R. (2012). Postoperative delirium: A 76-year-old woman with delirium following surgery. Journal of the American Medical Association, 308, 73-81.
    • (2012) Journal of the American Medical Association , vol.308 , pp. 73-81
    • Marcantonio, E.R.1
  • 33
    • 48249140622 scopus 로고    scopus 로고
    • Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics
    • doi:10.1002/hup.944
    • Martinotti, G., Andreoli, S., Di Nicola, M., Di Giannantonio, M., Sarchiapone, M., & Janiri, L. (2008). Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Human Psychopharmacology, 23, 417-424. doi:10.1002/hup.944
    • (2008) Human Psychopharmacology , vol.23 , pp. 417-424
    • Martinotti, G.1    Andreoli, S.2    Di Nicola, M.3    Di Giannantonio, M.4    Sarchiapone, M.5    Janiri, L.6
  • 34
    • 36049015484 scopus 로고    scopus 로고
    • Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: A randomized, placebo-controlled pilot study
    • McIntyre, A., Gendron, A., & McIntyre, A. (2007). Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: A randomized, placebo-controlled pilot study. Depression & Anxiety, 24, 487-494.
    • (2007) Depression & Anxiety , vol.24 , pp. 487-494
    • McIntyre, A.1    Gendron, A.2    McIntyre, A.3
  • 35
    • 83055184288 scopus 로고    scopus 로고
    • Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: A randomized, placebo controlled and active-controlled study
    • doi:10.1097/ YIC.0b013e32834d9f49
    • Merideth, C., Cutler, A.J., She, F., & Eriksson, H. (2012). Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: A randomized, placebo controlled and active-controlled study. International Clinical Psychopharmacology, 27, 40-54. doi:10.1097/ YIC.0b013e32834d9f49
    • (2012) International Clinical Psychopharmacology , vol.27 , pp. 40-54
    • Merideth, C.1    Cutler, A.J.2    She, F.3    Eriksson, H.4
  • 36
    • 33847197130 scopus 로고    scopus 로고
    • Clinical experience of quetiapine in 24 elderly patients with delirium
    • doi:10.1046/ j.1479-8301.2003.00012.x
    • Omura, K., & Amano, N. (2003). Clinical experience of quetiapine in 24 elderly patients with delirium. Psychogeriatrics, 3, 69-72. doi:10.1046/ j.1479-8301.2003.00012.x
    • (2003) Psychogeriatrics , vol.3 , pp. 69-72
    • Omura, K.1    Amano, N.2
  • 39
    • 34548565620 scopus 로고    scopus 로고
    • Quetiapine versus risperidone in elderly patients with behavioral and psychological symptoms of dementia: Efficacy, safety, and cognitive function
    • Rainer, M., Haushofer, M., Pfolz, H., Struhal, C., & Wick, W. (2007). Quetiapine versus risperidone in elderly patients with behavioral and psychological symptoms of dementia: Efficacy, safety, and cognitive function. European Psychiatry, 22, 395-403.
    • (2007) European Psychiatry , vol.22 , pp. 395-403
    • Rainer, M.1    Haushofer, M.2    Pfolz, H.3    Struhal, C.4    Wick, W.5
  • 40
    • 82955198411 scopus 로고    scopus 로고
    • A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving
    • doi:10.1007/s00213-011-2287-3
    • Ray, L.A., Chin, P.F., Heydari, A., & Miotto, K. (2011). A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol craving. Psychopharmacology, 217, 341-351. doi:10.1007/s00213-011-2287-3
    • (2011) Psychopharmacology , vol.217 , pp. 341-351
    • Ray, L.A.1    Chin, P.F.2    Heydari, A.3    Miotto, K.4
  • 41
    • 34548418494 scopus 로고    scopus 로고
    • Additional evidence of the abuse potential of quetiapine
    • Reeves, R.R., & Brister, J.C. (2007). Additional evidence of the abuse potential of quetiapine. Southern Medical Journal, 100, 834-836.
    • (2007) Southern Medical Journal , vol.100 , pp. 834-836
    • Reeves, R.R.1    Brister, J.C.2
  • 42
    • 84927016502 scopus 로고    scopus 로고
    • Pharmacotherapy in severe personality disorders: A critical review
    • In B. van Luyn & S. Akthar (Eds.), New York: Cambridge University
    • Rinne, T., & Ingenhoven, T. (2007). Pharmacotherapy in severe personality disorders: A critical review. In B. van Luyn & S. Akthar (Eds.), Severe personality disorders (pp. 137-163). New York: Cambridge University.
    • (2007) Severe Personality Disorders , pp. 137-163
    • Rinne, T.1    Ingenhoven, T.2
  • 43
    • 54749118885 scopus 로고    scopus 로고
    • Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: An open label trial
    • doi:10.1055/s-2008-1076730
    • Roepke, S., Merkl, A., Dams, A., Ziegenhorn, A., Anghelescu, I.G., Heuser, I., & Lammers, C.H. (2008). Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: An open label trial. Pharmacopsychiatry, 41, 176-181. doi:10.1055/s-2008-1076730
    • (2008) Pharmacopsychiatry , vol.41 , pp. 176-181
    • Roepke, S.1    Merkl, A.2    Dams, A.3    Ziegenhorn, A.4    Anghelescu, I.G.5    Heuser, I.6    Lammers, C.H.7
  • 44
    • 57149139518 scopus 로고    scopus 로고
    • Quetiapine in patients with borderline personality disorder: An openlabel trial
    • doi:10.1080/10401230802467545
    • Romine, A., Brown, E., Thuras, P., Lee, S., & Schulz, S.S. (2008). Quetiapine in patients with borderline personality disorder: An openlabel trial. Annals of Clinical Psychiatry, 20, 219-226. doi:10.1080/10401230802467545
    • (2008) Annals of Clinical Psychiatry , vol.20 , pp. 219-226
    • Romine, A.1    Brown, E.2    Thuras, P.3    Lee, S.4    Schulz, S.S.5
  • 45
    • 11344260664 scopus 로고    scopus 로고
    • Potential benefits of quetiapine in the treatment of substance abuse disorders
    • Sattar, P.S., Bhatia, S.C., & Petty, F. (2004). Potential benefits of quetiapine in the treatment of substance abuse disorders. Journal of Psychiatric Neurosciences, 29, 452-457.
    • (2004) Journal of Psychiatric Neurosciences , vol.29 , pp. 452-457
    • Sattar, P.S.1    Bhatia, S.C.2    Petty, F.3
  • 46
    • 33644922637 scopus 로고    scopus 로고
    • Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials
    • Schneider, L.S., Dagerman, K., & Insel, P.S. (2006). Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. American Journal of Geriatric Psychiatry, 14, 191-210.
    • (2006) American Journal of Geriatric Psychiatry , vol.14 , pp. 191-210
    • Schneider, L.S.1    Dagerman, K.2    Insel, P.S.3
  • 47
    • 34249982606 scopus 로고    scopus 로고
    • Successful treatment with quetiapine for delirium in terminally ill cancer patients
    • doi:10.1111/j.14798301.2007.00182.x
    • Shinno, H., Matsuoka, T., Yamamoto, O., Noma, Y., Hikasa, S., Takebayashi, M., & Horiguchi, J. (2007). Successful treatment with quetiapine for delirium in terminally ill cancer patients. Psychogeriatrics, 7, 64-68. doi:10.1111/j.14798301.2007.00182.x
    • (2007) Psychogeriatrics , vol.7 , pp. 64-68
    • Shinno, H.1    Matsuoka, T.2    Yamamoto, O.3    Noma, Y.4    Hikasa, S.5    Takebayashi, M.6    Horiguchi, J.7
  • 48
    • 41849148995 scopus 로고    scopus 로고
    • Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: Preliminary findings
    • doi:10.1007/s00213-008-1087-x
    • Simon, N.M., Connor, K.M., Lebeau, R.T., Hoge, E.A., Worthington, J.J., 3rd, Zhang W., Pollack, M.H. (2008). Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: Preliminary findings. Psychopharmacology, 197, 675-681. doi:10.1007/s00213-008-1087-x
    • (2008) Psychopharmacology , vol.197 , pp. 675-681
    • Simon, N.M.1    Connor, K.M.2    Lebeau, R.T.3    Hoge, E.A.4    Worthington III, J.J.5    Zhang, W.6    Pollack, M.H.7
  • 50
    • 83855161521 scopus 로고    scopus 로고
    • Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: An analysis of pooled data from three 8-week placebo-controlled studies
    • doi:10.1002/hup.1256
    • Stein, D.J., Bandelow, B., Merideth, C., Olausson, B., Szamosi, J., & Eriksson, H. (2011). Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: An analysis of pooled data from three 8-week placebo-controlled studies. Human Psychopharmacology, 26, 614-628. doi:10.1002/hup.1256
    • (2011) Human Psychopharmacology , vol.26 , pp. 614-628
    • Stein, D.J.1    Bandelow, B.2    Merideth, C.3    Olausson, B.4    Szamosi, J.5    Eriksson, H.6
  • 51
    • 84882698643 scopus 로고    scopus 로고
    • Study for off-label drug use urgently needed
    • Study for off-label drug use urgently needed. (2008). PharmacoEconomics & Outcomes News, 568, 8.
    • (2008) PharmacoEconomics & Outcomes News , vol.568 , pp. 8
  • 52
    • 46749095495 scopus 로고    scopus 로고
    • Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial
    • doi:10.1176/ appi.ajp.2008.07111779
    • Sultzer, D.L., Davis, S.M., Tariot, P.N., Dagerman, K.S., Lebowitz, B.D., Lyketsos, C.G., Schneider, L.S. (2008). Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial. American Journal of Psychiatry, 165, 844-854. doi:10.1176/ appi.ajp.2008.07111779
    • (2008) American Journal of Psychiatry , vol.165 , pp. 844-854
    • Sultzer, D.L.1    Davis, S.M.2    Tariot, P.N.3    Dagerman, K.S.4    Lebowitz, B.D.5    Lyketsos, C.G.6    Schneider, L.S.7
  • 57
    • 84859964525 scopus 로고    scopus 로고
    • Atypical antipsychotic medications to control symptoms of delirium in children and adolescents
    • Turkel, S.B., Jacobson, J., Munzig, E., & Tavaré, C.J. (2012). Atypical antipsychotic medications to control symptoms of delirium in children and adolescents. Journal of Child and Adolescent Psychopharmacology, 22, 126-130. doi:10.1089/cap.2011.0084
    • (2012) Journal of Child and Adolescent Psychopharmacology , vol.22 , pp. 126-130
    • Turkel, S.B.1    Jacobson, J.2    Munzig, E.3    Tavaré, C.J.4
  • 58
    • 84882717534 scopus 로고    scopus 로고
    • U.S. Department of Justice. (2010, April 27), [Press release]. Retrieved from
    • U.S. Department of Justice. (2010, April 27). million for off label drug marketing [Press release]. Retrieved from http://www.justice.gov/opa/pr/2010/April/10-civ-487.html
    • Million For Off Label Drug Marketing
  • 61
    • 27544468326 scopus 로고    scopus 로고
    • Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: Impulsivity as main target
    • Villeneuve, E., & Lemelin, S. (2005). Open-label study of atypical neuroleptic quetiapine for treatment of borderline personality disorder: Impulsivity as main target. Journal of Clinical Psychiatry, 66, 1298-1303.
    • (2005) Journal of Clinical Psychiatry , vol.66 , pp. 1298-1303
    • Villeneuve, E.1    Lemelin, S.2
  • 63
    • 79959620914 scopus 로고    scopus 로고
    • Quetiapine in refractory hyperactive and mixed intensive care delirium: A case series
    • Wan, R.Y., Kasliwal, M., McKenzie, C.A., & Barrett, N.A. (2011). Quetiapine in refractory hyperactive and mixed intensive care delirium: A case series. Critical Care, 15, R159.
    • (2011) Critical Care , vol.15
    • Wan, R.Y.1    Kasliwal, M.2    McKenzie, C.A.3    Barrett, N.A.4
  • 65
    • 77957681242 scopus 로고    scopus 로고
    • Statistically significant increase in weight gain caused by low-dose quetiapine
    • doi:10.1592/phco.30.10.1011
    • Williams, S.G., Alinejad, N.A., Williams, J.A., & Cruess, D.F. (2010). Statistically significant increase in weight gain caused by low-dose quetiapine. Pharmacotherapy, 30, 1011-1015. doi:10.1592/phco.30.10.1011
    • (2010) Pharmacotherapy , vol.30 , pp. 1011-1015
    • Williams, S.G.1    Alinejad, N.A.2    Williams, J.A.3    Cruess, D.F.4
  • 66
    • 33847132248 scopus 로고    scopus 로고
    • Quetiapine to treat agitation in dementia: A randomized, double-blind, placebo-controlled study
    • Zhong, K.X., Tariot, P.N., Mintzer, J., Minkwitz, M.C., & Devine, N.A. (2007). Quetiapine to treat agitation in dementia: A randomized, double-blind, placebo-controlled study. Current Alzheimer Research, 4, 81-93.
    • (2007) Current Alzheimer Research , vol.4 , pp. 81-93
    • Zhong, K.X.1    Tariot, P.N.2    Mintzer, J.3    Minkwitz, M.C.4    Devine, N.A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.